prikaz prve stranice dokumenta Administration of tocilizumab in septic patients with pancytopenia and hyper-inflammatory syndrome
No public access
Scientific paper - Letter
Administration of tocilizumab in septic patients with pancytopenia and hyper-inflammatory syndrome
Annals of Hematology, 102 (2023), 9; 2633-2634. https://doi.org/10.1007/s00277-023-05335-x
Tomulić Brusich, Katarina; Juričić, Kazimir; Bobinac, Mirna; Milošević, Marko; Protić, Alen; Boban, Ana

Institutional repository: Repository of the University of Rijeka, Faculty of Medicine

Cite this document

Tomulić Brusich, K., Juričić, K., Bobinac, M., Milošević, M., Protić, A. & Boban, A. (2023). Administration of tocilizumab in septic patients with pancytopenia and hyper-inflammatory syndrome. Annals of Hematology, 102. (9), 2633-2634. doi: 10.1007/s00277-023-05335-x

Tomulić Brusich, Katarina, et al. "Administration of tocilizumab in septic patients with pancytopenia and hyper-inflammatory syndrome." Annals of Hematology, vol. 102, no. 9, 2023, pp. 2633-2634. https://doi.org/10.1007/s00277-023-05335-x

Tomulić Brusich, Katarina, Kazimir Juričić, Mirna Bobinac, Marko Milošević, Alen Protić and Ana Boban. "Administration of tocilizumab in septic patients with pancytopenia and hyper-inflammatory syndrome." Annals of Hematology 102, no. 9 (2023): 2633-2634. https://doi.org/10.1007/s00277-023-05335-x

Tomulić Brusich, K., et al. (2023) 'Administration of tocilizumab in septic patients with pancytopenia and hyper-inflammatory syndrome', Annals of Hematology, 102(9), pp. 2633-2634. doi: 10.1007/s00277-023-05335-x

Tomulić Brusich K, Juričić K, Bobinac M, Milošević M, Protić A, Boban A. Administration of tocilizumab in septic patients with pancytopenia and hyper-inflammatory syndrome. Annals of Hematology [Internet]. 2023 June 26 [cited 2024 May 17];102(9):2633-2634. doi: 10.1007/s00277-023-05335-x

K. Tomulić Brusich, K. Juričić, M. Bobinac, M. Milošević, A. Protić and A. Boban, "Administration of tocilizumab in septic patients with pancytopenia and hyper-inflammatory syndrome", Annals of Hematology, vol. 102, no. 9, pp. 2633-2634, June 2023. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:497704. [Accessed: 17 May 2024]

Metadata
Title (english)Administration of tocilizumab in septic patients with pancytopenia and hyper-inflammatory syndrome
AuthorKatarina Tomulić Brusich
AuthorKazimir Juričić
AuthorMirna Bobinac
AuthorMarko Milošević
AuthorAlen Protić
AuthorAna Boban
Author's institutionUniversity of Rijeka
Faculty of Medicine
(Department of Anaesthesiology,reanimatology and Intensive Care)
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Clinical Medical Sciences
Anesthesiology and Reanimatology
Languageenglish
Publication typeScientific paper - Letter
Publication statusPublished
Peer reviewPeer review - international
Publication versionPublished version
Journal titleAnnals of Hematology
Numberingvol. 102, no. 9, pp. 2633-2634
p-ISSN0939-5555
e-ISSN1432-0584
DOIhttps://doi.org/10.1007/s00277-023-05335-x
URN:NBNurn:nbn:hr:184:497704
Publication2023-06-26
Document URLhttps://link.springer.com/10.1007/s00277-023-05335-x
Type of resourceText
Access conditionsClosed access
Terms of useLicence In copyright icon
Created on2023-11-13 13:38:37